(Q30332869)

18 June 2017

title

Immune Restoration Inflammatory Syndromes: The Dark Side of Successful Antiretroviral Treatment. (English)

1 reference

18 June 2017

main subject

anti-retroviral agent

0 references

author name string

Matthias Stoll

series ordinal

1

1 reference

18 June 2017

Reinhold E. Schmidt

series ordinal

2

1 reference

18 June 2017

publication date

1 June 2003

1 reference

Current infectious disease reports

18 June 2017

published in

1 reference

18 June 2017

volume

5

1 reference

18 June 2017

issue

3

1 reference

18 June 2017

page(s)

266-276

1 reference

Immune reconstitution syndromes in human immuno-deficiency virus infection following effective antiretroviral therapy

18 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11908-003-0083-X

Immunologic reconstitution after 1 year of highly active antiretroviral therapy, with or without protease inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-003-0083-X

Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-003-0083-X

Sarcoid-like pulmonary disorder in human immunodeficiency virus-infected patients receiving antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-003-0083-X

Effect of coexisting HIV-1 infection on the diagnosis and evaluation of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-003-0083-X

Cytomegalovirus retinitis in advanced HIV-infected patients treated with protease inhibitors: incidence and outcome over 2 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-003-0083-X

Transient clinical deterioration in HIV patients with Pneumocystis carinii pneumonia after starting highly active antiretroviral therapy: another case of immune restoration inflammatory syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-003-0083-X

Immune Restoration Syndrome Manifested by Pulmonary Sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-003-0083-X

Changes in thymic function with age and during the treatment of HIV infection

21 January 2018

1 reference

12 December 2020

Association of increased hepatitis C virus (HCV)-specific IgG and soluble CD26 dipeptidyl peptidase IV enzyme activity with hepatotoxicity after highly active antiretroviral therapy in human immunodeficiency virus-HCV-coinfected patients

1 reference

12 December 2020

Reactivation of hepatitis B in patients with human immunodeficiency virus infection treated with combination antiretroviral therapy

1 reference

12 December 2020

Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

1 reference

12 December 2020

CD4+ T-lymphocyte nadir and the effect of highly active antiretroviral therapy on phenotypic and functional immune restoration in HIV-1 infection.

1 reference

12 December 2020

Recurrent pulmonary sarcoidosis in HIV-infected patients receiving highly active antiretroviral therapy

1 reference

12 December 2020

CD4 T cell recovery is slower in patients experiencing viral load rebounds during HAART

1 reference

12 December 2020

Post-kala-azar dermal leishmaniasis manifesting after initiation of highly active anti-retroviral therapy in a patient with human immunodeficiency virus infection

1 reference

12 December 2020

AIDS-associated non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy.

1 reference

12 December 2020

Normalization of cytomegalovirus-specific CD4 T cells in HIV-1-infected individuals receiving antiretroviral therapy

1 reference

12 December 2020

Opportunistic infections occurring during highly active antiretroviral treatment

1 reference

12 December 2020

Recurrence of Mycobacterium avium infection in patients receiving highly active antiretroviral therapy and antimycobacterial agents

1 reference

12 December 2020

An evaluation of serum soluble CD30 levels and serum CD26 (DPPIV) enzyme activity as markers of type 2 and type 1 cytokines in HIV patients receiving highly active antiretroviral therapy

1 reference

12 December 2020

Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patients

1 reference

12 December 2020

Association between Kaposi's sarcoma and atherosclerosis: implications for gammaherpesviruses and vascular disease

1 reference

12 December 2020

Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy

1 reference

12 December 2020

Declining levels of rescued lymphoproliferative response to human cytomegalovirus (HCMV) in AIDS patients with or without HCMV disease following long-term HAART

1 reference

12 December 2020

Changes in the natural history of cytomegalovirus retinitis following the introduction of highly active antiretroviral therapy

1 reference

12 December 2020

Immune reconstitution syndrome after successful treatment of Pneumocystis carinii pneumonia in a man with human immunodeficiency virus type 1 infection

1 reference

12 December 2020

Polymorphisms in cytokine genes define subpopulations of HIV-1 patients who experienced immune restoration diseases

1 reference

12 December 2020

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies

1 reference

12 December 2020

Dermatological immune restoration syndrome: does it exist?

1 reference

12 December 2020

Mycobacterium avium complex lymph node abscess after use of highly active antiretroviral therapy in a patient with AIDS.

1 reference

12 December 2020

Cutaneous intolerance to tattoos in a patient with human immunodeficiency virus: a manifestation of the immune restoration syndrome.

1 reference

12 December 2020

The good and evil of HAART in HIV-related progressive multifocal leukoencephalopathy.

1 reference

12 December 2020

A case of immune reconstitution rheumatoid arthritis

1 reference

12 December 2020

Transient mobilization of human immunodeficiency virus (HIV)-specific CD4 T-helper cells fails to control virus rebounds during intermittent antiretroviral therapy in chronic HIV type 1 infection

1 reference

12 December 2020

Localized osteomyelitis due to Mycobacterium avium complex in patients with Human Immunodeficiency Virus receiving highly active antiretroviral therapy

1 reference

12 December 2020

Antiretroviral triple therapy decreases HIV viral load but does not alter hepatitis C virus (HCV) serum levels in HIV-HCV-co-infected haemophiliacs.

1 reference

12 December 2020

Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: an immune restoration disease?

1 reference

12 December 2020

Pentoxifylline in human immunodeficiency virus- positive tuberculosis: safety at 4 years

1 reference

12 December 2020

Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy

1 reference

12 December 2020

Influence of highly active antiretroviral therapy on the outcome of subclinical visceral leishmaniasis in human immunodeficiency virus-infected patients.

1 reference

12 December 2020

Recurrent Guillain-Barre syndrome as a complication of immune reconstitution in HIV

1 reference

12 December 2020

Changing trends in cytomegalovirus disease in HIV-infected patients

1 reference

12 December 2020

Cutaneous manifestations of antiretroviral therapy.

1 reference

12 December 2020

Microsporidial keratoconjunctivitis after HAART.

1 reference

12 December 2020

Case report. Toxoplasma encephalitis after initiation of HAART

1 reference

12 December 2020

Human papillomavirus-associated oral warts among human immunodeficiency virus-seropositive patients in the era of highly active antiretroviral therapy: an emerging infection

1 reference

12 December 2020

An unusual cluster of cases of Castleman's disease during highly active antiretroviral therapy for AIDS

1 reference

12 December 2020

Cerebral mycobacterium avium infection in an HIV-infected patient following immune reconstitution and cessation of therapy for disseminated mycobacterium avium complex infection

1 reference

12 December 2020

Atherosclerosis in AIDS: potential pathogenetic roles of antiretroviral therapy and HIV.

1 reference

12 December 2020

Dynamics of Epstein-Barr virus in HIV-1-infected subjects on highly active antiretroviral therapy

1 reference

12 December 2020

Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adults

1 reference

12 December 2020

Bacillary splenitis (Bartonella henselae) during immune restoration in an HIV-infected patient

1 reference

12 December 2020

Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function

1 reference

12 December 2020

Features of 'CD4-exploders', HIV-positive patients with an optimal immune reconstitution after potent antiretroviral therapy.

1 reference

12 December 2020

True gynaecomastia, another manifestation of immune reconstitution disease?

1 reference

12 December 2020

Osteonecrosis complicating highly active antiretroviral therapy in patients infected with human immunodeficiency virus

1 reference

12 December 2020

Lipodystrophy syndrome in HIV infection: what is it, what causes it and how can it be managed?

1 reference

12 December 2020

Mycobacterial cutaneous manifestations: a new sign of immune restoration syndrome in patients with acquired immunodeficiency syndrome

1 reference

12 December 2020

The maximal tolerable intravenous dosage of pentoxifylline in AIDS patients does not inhibit lipopolysaccharide-stimulated tumor necrosis factor alpha production

1 reference

12 December 2020

Impact of highly active antiretroviral therapy on the incidence of visceral leishmaniasis in a French cohort of patients infected with human immunodeficiency virus

1 reference

12 December 2020

T cell receptor excision circle (TREC) content following maximum HIV suppression is equivalent in HIV-infected and HIV-uninfected individuals

1 reference

12 December 2020

Severe, demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy

1 reference

12 December 2020

Case report. Severe cutaneous ulceration secondary to cytomegalovirus inclusion disease during successful immune reconstitution with HAART

1 reference

12 December 2020

Recurrences of cytomegalovirus retinitis in a human immunodeficiency virus-infected patient, despite potent antiretroviral therapy and apparent immune reconstitution

1 reference

12 December 2020

Potent antiretroviral therapy initiates normalization of hypergammaglobulinemia and a decline in HIV type 1-specific antibody responses

1 reference

12 December 2020

Sequential occurrence of thyroid autoantibodies and Graves' disease after immune restoration in severely immunocompromised human immunodeficiency virus-1-infected patients

1 reference

12 December 2020

Osteonecrosis in human immunodeficiency virus-infected patients may not be related to immune reconstitution

1 reference

12 December 2020

Increasing CD4+ T cells specific for tuberculosis correlate with improved clinical immunity after highly active antiretroviral therapy

1 reference

12 December 2020

Chronic erosive herpes simplex virus infection of the penis, a possible immune reconstitution disease.

1 reference

12 December 2020

Highly active antiretroviral therapy

1 reference

12 December 2020

Transient vitreous inflammatory reactions associated with combination antiretroviral therapy in patients with AIDS and cytomegalovirus retinitis

1 reference

12 December 2020

The extent of HIV-1-related immunodeficiency and age predict the long-term CD4 T lymphocyte response to potent antiretroviral therapy

1 reference

12 December 2020

Reconstitution of NK cell activity in HIV-1 infected individuals receiving antiretroviral therapy

1 reference

12 December 2020

Cytomegalovirus retinitis in the era of highly active antiretroviral therapy

1 reference

12 December 2020

Immune dysfunction and immune restoration disease in HIV patients given highly active antiretroviral therapy

1 reference

12 December 2020

Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease.

1 reference

12 December 2020

Immunorestitution disease involving the innate and adaptive response

1 reference

12 December 2020

Durability and predictors of success of highly active antiretroviral therapy for ambulatory HIV-infected patients

1 reference

12 December 2020

Herpes zoster as an immune reconstitution disease after initiation of combination antiretroviral therapy in patients with human immunodeficiency virus type-1 infection

1 reference

12 December 2020

Levels of IL-6 and soluble IL-6 receptor are increased in HIV patients with a history of immune restoration disease after HAART

1 reference

12 December 2020

Safe Interruption of Maintenance Therapy against Previous Infection with Four Common HIV-Associated Opportunistic Pathogens during Potent Antiretroviral Therapy

1 reference

12 December 2020

Is acute appendicitis another inflammatory condition associated with highly active antiretroviral therapy (HAART)?

1 reference

12 December 2020

Immune reconstitution pneumonitis following Pneumocystis carinii pneumonia in HIV-infected subjects.

1 reference

12 December 2020

Mediastinitis due to cryptococcal infection: a new clinical entity in the HAART era.

1 reference

12 December 2020

Cytomegalovirus (CMV) Retinitis Immune Restoration Disease Occurs during Highly Active Antiretroviral Therapy–Induced Restoration of CMV‐Specific Immune Responses within a Predominant Th2 Cytokine Environment

1 reference

12 December 2020

Alopecia universalis and Graves’ disease in the setting of immune restoration after highly active antiretroviral therapy

1 reference

12 December 2020

Normalization of immune activation in lymphoid tissue following highly active antiretroviral therapy

1 reference

12 December 2020

Human immunodeficiency virus-associated polymyositis during immune restoration with combination antiretroviral therapy

1 reference

12 December 2020

Exacerbation of the inflammatory response to Mycobacterium tuberculosis after antiretroviral therapy

1 reference

12 December 2020

10.1007/S11908-003-0083-X

Identifiers

DOI

1 reference

18 June 2017

1 reference